Charles Comins

666 total citations
19 papers, 250 citations indexed

About

Charles Comins is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Charles Comins has authored 19 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Charles Comins's work include Breast Cancer Treatment Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Charles Comins is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Charles Comins collaborates with scholars based in United Kingdom, Switzerland and Italy. Charles Comins's co-authors include Alan Melcher, Hardev Pandha, Kevin J. Harrington, Victoria Roulstone, Christine White, James Spicer, David E. Cohn, K.L. Mettinger, Andrew Protheroe and Katie Twigger and has published in prestigious journals such as Clinical Cancer Research, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Charles Comins

18 papers receiving 247 citations

Peers

Countries citing papers authored by Charles Comins

Since Specialization

Citations

This map shows the geographic impact of Charles Comins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Comins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Comins more than expected).

Fields of papers citing papers by Charles Comins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Comins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Comins. The network helps show where Charles Comins may publish in the future.

Co-authorship network of co-authors of Charles Comins

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Comins. A scholar is included among the top collaborators of Charles Comins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Comins. Charles Comins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Clinical and patient-reported outcomes in women offered oncoplastic breast-conserving surgery as an alternative to mastectomy: ANTHEM multicentre prospective cohort study 2024 ·British journal of surgery ·Charlotte Davies, Leigh Johnson, (unknown), Nicola Mills, Patricia Fairbrother, Chris Holcombe, Lisa Whisker, William Hollingworth, Joanna Skillman, Paul White, Douglas Macmillan, Charles Comins, Shelley Potter	1
2	Understanding decision-making for and against oncoplastic breast-conserving surgery as an alternative to a mastectomy in early breast cancer: UK ANTHEM qualitative study 2024 ·British journal of surgery ·Charlotte Davies, (unknown), Nicola Mills, Patricia Fairbrother, Chris Holcombe, Lisa Whisker, Joanna Skillman, Paul White, Douglas Macmillan, Charles Comins, William Hollingworth, Shelley Potter	3
3	76 Adjuvant Durvalumab post chemoradiotherapy in stage III unresectable non-small cell lung cancer: A retrospective review from the University Hospitals Bristol and Weston NHS Foundation Trusts 2024 ·Lung Cancer ·(unknown), G. Ayre, Helen Brooks, (unknown), Charles Comins, Adam Dangoor, (unknown)	0
4	Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis 2023 ·Frontiers in Oncology ·(unknown), (unknown), Roya Behrouzi, Alessio Signori, Judith Cave, Charles Comins, Alessio Cortellini, Alfredo Addeo, Carles Escriu, Hayley McKenzie, Gloria Barone, Lisa Murray, David J. Pinato, Christian H. Ottensmeier, Sara Campos, S. Muthuramalingam, Samuel H.H. Chan, Fábio Gomes, Giuseppe Luigi Banna	6
5	The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Roya Behrouzi, Alessio Signori, Judith Cave, Charles Comins, Alessio Cortellini, Alfredo Addeo, Carles Escriu, Hayley McKenzie, Gloria Barone, Lisa Murray, (unknown), David J. Pinato, Christian H. Ottensmeier, Fábio Gomes, Giuseppe Luigi Banna	3
6	Protocol for a prospective observational cohort study collecting data on demographics, symptoms and biomarkers in people with mesothelioma (ASSESS-meso) 2022 ·BMJ Open ·(unknown), (unknown), (unknown), (unknown), Charles Comins, Louise Stadon, John Harvey, Kevin G. Blyth, Nick Maskell, Anna Bibby	3
7	A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) — a randomised feasibility study using the trial within a cohort (TwiC) methodology 2022 ·Pilot and Feasibility Studies ·Anna Bibby, Natalie Zahan-Evans, Emma Keenan, Charles Comins, John Harvey, (unknown), Najib M. Rahman, (unknown), Rachael Gooberman‐Hill, Nick Maskell	5
8	Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study 2022 ·International Immunopharmacology ·Giuseppe Luigi Banna, Ornella Cantale, S. Muthuramalingam, Judith Cave, Charles Comins, Alessio Cortellini, Alfredo Addeo, Alessio Signori, Hayley McKenzie, Carles Escriu, Gloria Barone, (unknown), Alexander Hicks, (unknown), David J. Pinato, Christian H. Ottensmeier, Fábio Gomes	21
9	Protocol for a mixed-method study to inform the feasibility of undertaking a large-scale multicentre study comparing the clinical and patient-reported outcomes of oncoplastic breast conservation as an alternative to mastectomy with or without immediate breast reconstruction in women unsuitable for standard breast-conserving surgery (the ANTHEM Feasibility Study) 2021 ·BMJ Open ·Charlotte Davies, Christopher Holcombe, Joanna Skillman, Lisa Whisker, William Hollingworth, (unknown), Nicola Mills, Paul White, Charles Comins, Douglas Macmillan, Patricia Fairbrother, Shelley Potter	6
10	Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres 2018 ·Clinical Oncology ·(unknown), J. Lester, (unknown), (unknown), C. Esler, (unknown), Elizabeth Toy, J.F. Lester, M. Button, (unknown), Charles Comins, Philip J. Atherton, (unknown), K. Foweraker, (unknown), (unknown), M. Hatton	6
11	Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial 2018 ·Trials ·Duneesha de Fonseka, Anna Morley, Louise Stadon, Emma Keenan, Steven Walker, Sarah Smith, John Harvey, (unknown), Adam Dangoor, Charles Comins, Christine Rogers, Anthony Edey, Alfredo Addeo, Nick Maskell	5
12	Synergistic antitumour effects of rapamycin and oncolytic reovirus 2018 ·Cancer Gene Therapy ·Charles Comins, Guy R. Simpson, William Rogers, (unknown), Kevin J. Harrington, Alan Melcher, Victoria Roulstone, Joan Kyula, Hardev Pandha	9
13	The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study 2016 ·British Journal of Cancer ·(unknown), Tim Robinson, Charles Comins, Mike Shere, Mohini Varughese, (unknown), Ajay Sahu, (unknown), Amit Bahl, Simon Cawthorn, Jeremy Braybrooke	22
14	Radiographer-led breast boost localisation – A service evaluation study 2014 ·Radiography ·(unknown), Charles Comins	6
15	146 The use of stereotactic radiotherapy for the treatment of brain metastasis in patients with non-small cell lung cancer: a decade of experience from Bristol Oncology Centre 2014 ·Lung Cancer ·Lyndsay Harris, Kirsten Hopkins, (unknown), Charles Comins	1
16	A prospective multi-centre study of the impact of Oncotype DX (R) on adjuvant treatment decisions in patients in the UK with estrogen receptor positive early breast cancer 2013 ·European Journal of Cancer ·Jeremy Braybrooke, (unknown), Thompson Robinson, Charles Comins, (unknown), M. Varughese, (unknown), (unknown), Aditi Sahu, S. Cawthorn	1
17	REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer 2010 ·Clinical Cancer Research ·Charles Comins, James Spicer, Andrew Protheroe, Victoria Roulstone, Katie Twigger, Christine White, Richard G. Vile, Alan Melcher, Matt Coffey, K.L. Mettinger, Gerard J. Nuovo, David E. Cohn, Mitch A. Phelps, Kevin J. Harrington, Hardev Pandha	109
18	Reovirus: Viral Therapy for Cancer ‘as Nature Intended’ 2008 ·Clinical Oncology ·Charles Comins, Lucy Heinemann, Kevin J. Harrington, Alan Melcher, Johann S. de Bono, Hardev Pandha	39
19	Results of a UK survey on methods for compensating for unscheduled treatment interruptions and errors in treatment delivery 2007 ·British Journal of Radiology ·Roger Dale, Bleddyn Jones, Judith Sinclair, Charles Comins, Efstathios Antoniou	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact